GSK has secured its first global regulatory approval for Hibsago(bepirovirsen), marking the debut of a functional cure option for chronic hepatitis B (CHB) anywhere in...
Emcure Pharmaceuticals Ltd announced that its co-marketed semaglutide brand, Poviztra®, has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) for the...